Orthopaedics Today Europe Current Issue

The following articles appeared in the print edition of Orthopaedics Today Europe.

Table of Contents

• Assess symptoms, knee function to achieve successful revision TKA outcomes
• Bone-patellar tendon-bone and hamstring autografts show similar endoscopic ACL reconstruction results
• Combined chemotherapy and surgery improve post-radiation sarcoma prognosis
• EBOT Exam 2013
• EBOT Interim Exam
• EFORT invites you to Istanbul in the early summer of 2013
• European Parliament ITRE Committee vote paves the way for inclusion of musculoskeletal diseases in the future EU Framework Programme for Research and Innovation, Horizon 2020
• Fibular nail fosters union of unstable fibular fractures
• High flexion TKR device shows more flexion than standard TKR prosthesis
• Lengthening osteotomy, flexor digitorum longus transfer reliable for flatfoot deformity correction
• Low complication rates seen with sequential, bilateral uni knee replacements
• New Bone & Joint/EFORT Travelling Fellowship - application now open
• OTE200: Technology advancements
• Postoperative urinary tract infection linked to deep infection after hip fracture surgery
• Study questions inflammation as a component of trochanteric bursitis
• UK researchers find genetic marker for intervertebral disc degeneration
• Key issues of 2012 may concern orthopaedic surgeons in 2013 and beyond Per Kjaersgaard-Andersen, MD
• Low back pain frequency no different for elite athletes and non-athletes
• Microfracture, bone marrow concentrate shows good early results in treatment of focal lesions
• Remplissage with Bankart repair of Hills-Sachs defects helps reduce recurrence rates
• Reverse shoulder arthroplasty improves damage from inflammatory arthritis
• DJO Global acquires Exos Corporation
• EOS imaging appoints new chairman of the board
• K2M announces Italian launch of spine, retractor systems
• Reinhardt named worldwide president of DePuy Synthes Spine
• Stryker names Bruder vice president, chief medical and scientific officer
• Smith & Nephew enters into agreement with Healthpoint Biotherapeutics
• Crowe classification may not clearly indicate degree of hip dysplasia
• Femoral stem impaction grafting is durable, reliable for treatment of acetabular defects
• Management of TJA infection with two-stage exchange involves careful screening, team approach
• Stem design enhancements affect cementless THA results